ATI RN
Quizlet Pharmacology ATI Questions
Question 1 of 5
A patient has been changed from a first generation H1 receptor antagonist to a second generation H1 receptor antagonist. The nurse evaluates that the patient understands the benefit of this change when which statement is made?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
The following drugs are absorbed predominantly through active transport systems:
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
How can central venous access devices (CVADs) be of value in a patient receiving chemotherapy who has stomatitis and severe diarrhea?
Correct Answer: D
Rationale: Central venous access devices (CVADs) can be of value in a patient receiving chemotherapy who has stomatitis and severe diarrhea by allowing concentrated hyperalimentation fluid to be administered through the CVAD. Stomatitis and severe diarrhea can significantly affect oral intake and absorption of nutrients, leading to malnutrition and dehydration. By administering concentrated hyperalimentation fluid through a CVAD, the patient can receive the necessary nutrition and hydration directly into the bloodstream, bypassing the gastrointestinal tract. This can help maintain the patient's nutritional status and manage dehydration effectively during chemotherapy treatment.
Question 4 of 5
Which condition does the nurse identify as a late manifestation of hypokalemia?
Correct Answer: C
Rationale: Palpitations are a late manifestation of hypokalemia. Hypokalemia is a condition characterized by low levels of potassium in the blood, which can affect the heart's ability to function properly. Palpitations, or irregular heartbeat, can occur as a result of the heart's increased sensitivity to adrenaline due to low potassium levels. Other early manifestations of hypokalemia include muscle weakness, which is a result of potassium's role in muscle contraction, hypotension (low blood pressure), and lethargy.
Question 5 of 5
The nurse will monitor for myopathy (muscle pain) when a patient is taking which class of antilipemic drugs?
Correct Answer: B
Rationale: Myopathy, characterized by muscle pain or weakness, is a potential side effect associated with the use of HMG-CoA reductase inhibitors, also known as statins. Common examples of statins include atorvastatin, simvastatin, and rosuvastatin. Patients taking statins should be monitored for any signs or symptoms of myopathy, as it can progress to a more serious condition called rhabdomyolysis, where muscle breakdown products can lead to kidney damage. Monitoring for muscle pain, weakness, and elevated creatine kinase levels is essential to detect and manage myopathy promptly in patients on statin therapy.